Key result
Dilated cardiomyopathy is linked to elevated actin and myosin autoantibodies compared to healthy controls.
Why the study?
Autoantibodies against actin and myosine have been detected at higher levels in patients with dilated cardiomyopathy compared to healthy donors, but differences in immunogenicity between affected and normal myocardial proteins remain unclear.
Case-Control (n=83)
Patients with dilated cardiomyopathy exhibit elevated autoantibodies against actin and myosin, with differences in immunogenicity likely related to higher-level structural changes rather than primary protein structure.
Answers are grounded in this paper and cite their sources.
Should not yet change dilated cardiomyopathy management; hypothesis-generating for myocardial autoimmunity's role.
The autoantibodies directed against actin and myosine have been detected in the blood sera of patients with dilated cardiomyopathy (DCMP) at the level that was sufficiently higher than in healthy donors.While comparing of the immunogeneicity of these pro teins we have stated that myosine from affected by DCMP myocardium have been more immunogenic then from normal one.In the case of actin the immunogeneicity have been higher for the protein from normal myocard.The investigations of actin by limited proteolysis may suggest that the differencies in immune properties are not connected with primary structure but with structures of higher levels.
No takes yet. Share an insight, caveat, or question.
Сидорик et al. (1995) conducted a case-control in Dilated cardiomyopathy (n=83). Dilated cardiomyopathy vs. Healthy donors was evaluated on Immunoreactivity of sera against actin and myosin. Patients with dilated cardiomyopathy had higher levels of autoantibodies against actin and myosin compared to healthy donors, with myosin from affected myocardium showing greater immunogenicity.
Synapse has enriched 10 related papers. Consider them for comparative context: